Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase III, Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety of Once Daily Esomeprazole for the Treatment of Clinically Diagnosed Gastroesophageal Reflux Disease (GERD) in Pediatric and Adolescent Patients 12 to 17 Years of Age, Inclusive https://kusajili.com:443/Trial/RyBVcxCSGEuxJ6b30wgkKA%24a-phase-iii-multicenter-randomized-double-blind-parallel-group-study-to-evaluate-the-safety-of-once-daily-esomeprazole-for-the-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message